Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
Atezolizumab for untreated PD-L1 positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (CDF review TA492) (ID3777)

National Institute for Health Research · United Kingdom · £328.1K GBP

Grant Information

Provide details about the grant you are applying for


$
Applicant Information

Tell us about yourself and your organization


$
Proposal & Supporting Documents

Provide additional details and upload your proposal document


Accepted formats: PDF, DOC, DOCX. Max size: 10MB